|
|
Macrodantin no Prescription |
Buy Macrodantin no Prescription
|
What are Macrodantin no Prescription used for?
Nitrofurantoin, an antibacterial drug, is prescribed for the treatment of urinary tract infections caused by certain strains of bacteria.
What are the possible side effects of Macrodantin no Prescription? Macrodantin no Prescription side effects that you should report to your health care professional or doctor as soon as possible:
- Vomiting;
- Nausea;
- Lack Or Loss Of Appetite;
What is a recommended dosage of Macrodantin no Prescription?
Treatment with nitrofurantoin should be continued for 1 week or for at least 3 days after obtaining a urine specimen free of infection. If your infection has not cleared up, your doctor should re-evaluate your case.
ADULTS
The recommended dosage of Macrodantin, Nifuran, Nitrofurantoin, Furadantin is 50 to 100 mg taken 4 times a day. For long-term treatment, your doctor may reduce your dosage to 50 to 100 mg taken at bedtime.
The recommended dosage of Macrobid is one 100 mg capsule every 12 hours for 7 days.
CHILDREN
This medication should not be prescribed for children under 1 month of age.
The recommended daily dosage of Macrodantin, Nifuran, Nitrofurantoin, Furadantin for infants and children over 1 month of age is 5 to 7 mg per 2.2 pounds of body weight, divided into 4 doses over 24 hours.
For the long-term treatment of children, the doctor may prescribe daily doses as low as 1 mg per 2.2 pounds of body weight taken in 1 or 2 doses per day.
The dosage of Macrobid for children over 12 years of age is one 100 mg capsule every 12 hours for 7 days. Safety and effectiveness have not been established for children under 12.
OLDER ADULTS
Doctors tend to prescribe lower doses of Macrodantin, Nifuran, Nitrofurantoin, Furadantin for older adults. The drug is more likely to cause lung and liver problems in members of this group; and because more older adults have poor kidneys, the risk of toxic reactions to Macrodantin, Nifuran, Nitrofurantoin, Furadantin is also greater.
|
|
|
|
